MD Stock Recent News
MD LATEST HEADLINES
MD launches a $250M buyback, fueled by stronger cash flow, leaner operations and robust 2025 profit outlook.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Announces $250 Million Share Repurchase Program.
Does Pediatrix Medical Group (MD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
MD's Q2 earnings benefit from higher patient volumes and a declining expense level. It now projects 2025 adjusted EBITDA within $245-$255 million, up from the prior view of $220-$240 million.
Pediatrix Medical Group (MD 5.04%), a leader in neonatal and maternal-fetal healthcare services, reported its second-quarter 2025 earnings on August 5, 2025. The company delivered a standout quarter, with non-GAAP earnings per share (EPS) of $0.53, beating analyst expectations of $0.42 by 25.9% (non-GAAP).
Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Kasandra H. Rossi - Executive VP, Treasurer & CFO Mark S.
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.34 per share a year ago.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results.